Stoke Therapeutics Inc

General ticker "STOK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $687.2M

Stoke Therapeutics Inc follows the US Stock Market performance with the rate: 45.7%.

Estimated limits based on current volatility of 4.6%: low 10.65$, high 11.68$

Factors to consider:

  • Current price 35.3% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.13$, 8.58$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.00$, 10.03$]

Financial Metrics affecting the STOK estimates:

  • Negative: Non-GAAP EPS, $ of -2.37 <= 0.10
  • Negative: Operating profit margin, % of -92.89 <= 1.03
  • Negative: Operating cash flow per share per price, % of -28.36 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term STOK quotes

Long-term STOK plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $12.40MM $8.78MM
Operating Expenses $86.06MM $116.76MM $123.55MM
Operating Income $-86.06MM $-104.36MM $-114.77MM
Non-Operating Income $0.26MM $3.29MM $10.07MM
Interest Expense $0.12MM $3.12MM $0.00MM
R&D Expense $54.17MM $77.84MM $82.23MM
Income(Loss) $-85.81MM $-101.07MM $-104.70MM
Profit(Loss) $-85.81MM $-101.07MM $-104.70MM
Stockholders Equity $217.78MM $184.85MM $159.56MM
Inventory $0.00MM $10.93MM $0.00MM
Assets $238.87MM $256.07MM $228.34MM
Operating Cash Flow $-66.91MM $-31.87MM $-81.07MM
Capital expenditure $1.20MM $3.96MM $1.62MM
Investing Cash Flow $-76.43MM $-45.88MM $105.95MM
Financing Cash Flow $1.28MM $46.41MM $53.01MM
Earnings Per Share* $-2.31 $-2.39 $-2.38

* EPS are Split Adjusted, recent splits may be reflected with a delay.